(Hypertension. 2002;40:214.)
© 2002 American Heart Association, Inc.
Scientific Contributions |
From the Department of Pharmacology and Toxicology, Medical College of Wisconsin (P.F.P., L.M.L., N.J.R.), Milwaukee; Laboratoire de Physiologie Cellulaire Respiratoire, INSERM 9937, Universite Bordeaux 2 (S.B.), Bordeaux, France; and Laboratoire de Physiopathologie de la paroie Arterielle, Faculty of Medicine (P.B.), Tours, France.
Correspondence to Dr Nancy J. Rusch, Department of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226. E-mail nrusch{at}mcw.edu
| Abstract |
|---|
|
|
|---|
1C subunit of the L-type Ca2+ channel underlies this ionic defect. With the use of mesenteric arcade arteries from 12- to 16-week-old SHR and normotensive Wistar Kyoto (WKY) rats, reverse transcriptasepolymerase chain reaction demonstrated an increased level of amplified cDNA corresponding to the
1C subunit mRNA in the SHR arteries. Western blots confirmed that the increased mRNA expression was associated with a 3.4-fold increase in the immunoreactive signal of the
1C subunit protein in SHR compared with WKY mesenteric arteries, and immunocytochemistry confirmed this abnormality at the single-cell level. Finally, isolated mesenteric arteries from SHR were highly reactive to Bay K8644 and developed anomalous Ca2+-dependent tone, suggesting a functional role for
1C subunit upregulation in vascular hyperreactivity. To determine if these Ca2+ channel abnormalities extended to the SHR skeletal muscle bed, we repeated a similar series of studies in WKY and SHR hind limb arteries. Skeletal muscle arteries from SHR also expressed higher levels of
1C subunit mRNA and protein than WKY arteries and developed anomalous Ca2+-dependent tone attributed to L-type Ca2+ channels. Our data provide the first evidence that the
1C subunit mRNA and protein are upregulated in SHR arteries and that the increased numbers of L-type Ca2+ channel pores are associated with the generation of abnormal vascular tone.
Key Words: calcium channels muscle, smooth, vascular arteries mesenteric arteries rats, spontaneously hypertensive hypertension, arterial
| Introduction |
|---|
|
|
|---|
Recently, however, studies using mesenteric arteries as a model have shown that VSMCs of SHR, studied in patch-clamp conditions that tightly control cell membrane potential and environment, still exhibit an enhanced voltage-gated Ca2+ influx compared with WKY cells. Ohya et al12 demonstrated a higher membrane density of L-type Ca2+ current in mesenteric VSMC of 5- to 6-week-old SHR compared with age-matched WKY rats, although density was normalized in SHR by 16 to 18 weeks of age. No differences in L-type Ca2+ channel properties were detected between these preparations. In detailed studies, Cox and Lozinskaya13,14 detected a higher density of L-type Ca2+ current in mesenteric VSMC from 6-, 12-, and 20-week-old SHR and observed normal voltage-dependent activation of the SHR Ca2+ channel. Finally, single-channel analysis by Ohya and colleagues15 in cell-attached patches revealed that single L-type Ca2+ channels in WKY and SHR mesenteric VSMCs have similar unitary conductances and open-time distributions, although SHR membrane patches showed an enhanced number of channel openings. With the notation that a small hyperpolarizing shift in SHR channel activation was reported in 20-week-old SHR that would tend to increase channel availability, 14 all of these findings are consistent with the hypothesis that L-type Ca2+ channels are upregulated in SHR mesenteric VSMC membranes. However, an increased protein expression of the channel pores has not been demonstrated.
The goal of this study was to compare the mRNA and protein expression levels of L-type Ca2+ channel pores between mesenteric VSMCs of WKY rats and SHR and to determine if altered Ca2+ channel expression is associated with abnormalities in the reactivity of isolated arteries. Similar experiments also were conducted in VSMC and segments of rat skeletal muscle arteries to examine the profile of L-type Ca2+ channel alterations in another vascular bed involved in blood pressure regulation.
| Methods |
|---|
|
|
|---|
Reverse TranscriptasePolymerase Chain Reaction
Total RNA was isolated and pooled from 3 WKY or SHR arteries with the use of an RNeasy Mini Kit (Qiagen). First-strand cDNA was synthesized from 1 µg of total RNA (First-Strand Beads, Amersham Pharmacia Biotech). Duplex polymerase chain reaction (PCR) was performed according to commercial instructions with 3.5 µL of reverse transcriptase (RT) product and TaKaRA LA Taq polymerase (TaKaRa Biomedicals). Sense and antisense primers (Operon Technologies) were designed from coding regions of the
1C subunit (nt 5790 to 5809; 6003 to 6022; M59786) and smooth musclespecific
-actin (nt 151 to 174; 765 to 787; NM007392). Primers for
-actin spanned intronic sequences in the
-actin gene to permit the detection of genomic DNA contamination in PCR reactions. The PCR conditions including annealing temperature and cycle dependency were initially optimized. PCR was begun with a 5-minute denaturation at 95°C followed by 32 to 40 cycles of 95°C (1 minute), 59°C (1 minute), 72°C (2 minutes), and a final extension step at 72°C (5 minutes). Amplified cDNA products were analyzed on a 1% agarose gel with a 100-bp DNA ladder as a marker. The photodensity of amplified cDNA product bands were quantified by densitometry (Alpha Innotech Corp).
Western Blotting
Membrane proteins were isolated and pooled from 4 to 8 WKY rats or SHR for use in Western blots.16 A sequence-specific polyclonal antibody, anti-
1C, raised against residues 818 to 835 of the
1C subunit, was used. Anti-
1C was a kind gift from Dr Joerg Striessnig (University of Innsbruck) or was obtained commercially (Alomone Laboratories, Jerusalem).
-Actin (Sigma) was used as an internal standard.16 The bound antibody was detected by chemiluminescence (ECL, Amersham) and the densities of the doublet bands at 200 and 240 kDa were summed to evaluate the level of
1C subunit expression.
Immunocytochemistry
Single VSMCs were enzymatically isolated17 and fixed with 95% ethanol on glass coverslips. Immunostaining was performed at 37°C for 45 minutes with antibodies directed against the
1C subunit or
-actin. Antibodies were diluted 1:50 (
1C) or 1:100 (
-actin) in phosphate-buffered saline containing 3% normal goat serum and 0.2% Tween 20 (PBS-NGT). After washing, incubations with the secondary Alexa Fluor 594 antibodies (Jackson Immunoresearch) were performed at 37°C for 30 minutes. Finally, nuclei were stained with 4', 6-diamidino-2-phenylindole (DAPI; Sigma). Fluorescent signals were compared between populations of VSMCs isolated in parallel from WKY and SHR arteries on the same day with NIH software (Scion Image), and the SHR signal was normalized to the average WKY value for statistical analysis.
Vascular Reactivity Assays
Mesenteric and femoral arteries (3-mm length) were mounted in a tension-recording system,18 and optimal basal tension was established at 1.0 g. After 1 hour, 2 successive contractions to 80 mmol/L KCl were recorded. Subsequently, concentration-dependent responses to the dihydropyridine agonist, Bay K8644 (Sigma), were obtained in one set of arteries. Another set of arteries was maintained in control PSS, and spontaneous changes in vessel reactivity were recorded for 90 minutes or until stable. The level of active basal tone mediated by L-type Ca2+ channels was evaluated by application of 1 µmol/L nifedipine (Sigma) at the end of the experiment.
Statistics
Data are expressed as mean±SEM. Significant differences between SHR and WKY preparations were determined by Students t test or 1-way ANOVA with repeated measures. A probability value of <0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
1C Gene Is Upregulated in Mesenteric VSMCs of SHR
1C subunit between mesenteric VSMCs of WKY rats and SHR. Figure 1A shows the cycle-dependent amplification of 637-bp and 233-bp products corresponding to mRNA for smooth muscle
-actin and the
1C subunit in WKY arteries, respectively. The graph indicates that linear amplification occurred between 28 and 36 cycles. Figure 1B shows that compared with WKY (top panel), the photodensities of the 233-bp bands corresponding to
1C mRNA were substantially higher in SHR arteries (bottom panel). At the same cycle number,
-actin was equally amplified, providing evidence of experimental consistency between reactions. RNA isolations pooled from a total of 6 WKY and 6 SHR arteries demonstrated a 1.53-fold increase in the
1C signal measured in the linear range. Performing amplification without RT reaction or in the absence of specific primers produced no detectable products (data not shown).
|
1C Subunit Is Overexpressed in Mesenteric VSMCs of SHR
Western blotting compared the expression of the
1C subunit protein between mesenteric VSMC membranes of WKY rats and SHR. The left lane in Figure 1C reveals the presence of 200- and 240-kDa doublet bands in mesenteric membranes from WKY rats corresponding to the short and long forms of the
1C subunit.16 In the right lane, the doublet bands were abolished by preabsorption of the antibody with 3 µmol/L of its antigenic competing peptide (+CP), confirming antibody specificity for its recognition sequence. The similar immunodensity of the
-actin (45 kDa) internal standard in both lanes verified uniform lane loading of 10 µg protein. Figure 1D displays a subsequent Western blot showing a striking upregulation of the
1C subunit in SHR compared with WKY mesenteric membranes. The film exposure was minimized to visualize the WKY bands without saturating the SHR signal. In 6 separate comparisons using different protein isolations, the immunoreactive signals associated with the
1C subunit were 3.4-fold higher in SHR compared with WKY, representing a significant elevation of the L-type Ca2+ channel protein. To determine if the overexpression of
1C subunits is an early feature of SHR arteries, Western analysis was extended to mesenteric arteries pooled from 4-week old WKY rats and SHR. Interestingly, the inset in Figure 1D shows that the
1C subunit was not upregulated in the arteries of the young SHR.
Subsequently, mesenteric VSMCs from adult WKY rats and SHR were freshly isolated for immunocytochemical analysis, and a total of 39 cells were analyzed individually for fluorescent intensities. The left 2 panels in Figure 2A show a Nomarski image of mesenteric VSMCs isolated from WKY rats and SHR arteries, respectively, on the same day. The right 2 panels demonstrate that the fluorescent signals from the SHR cells labeled with the anti-
1C antibody were higher than in the WKY cells when exposed for equivalent times, showing a significantly increased average intensity of 1.6-fold in the SHR cell population. Figure 2B demonstrates that the fluorescent signal for
-actin did not significantly differ between WKY and SHR VSMCs. Notably, cell immunofluorescence was absent in control reactions obtained without primary antibodies. Furthermore, Figure 2C demonstrates that immunofluorescence was absent in WKY and SHR VSMCs exposed to the
1C antibody after it was preadsorbed with its antigenic competing peptide.
|
SHR Mesenteric Arteries Show More Functional
1C Subunits
Vascular reactivity responses to the L-type Ca2+ channel agonist Bay K8644 and to the channel antagonist nifedipine were performed to compare L-type Ca2+ channel-dependent changes in contractility between WKY and SHR mesenteric arteries. The traces in Figure 3A show that cumulative concentrations of Bay K8644 weakly contracted WKY arteries but profoundly contracted SHR arteries. Figure 3B shows that SHR arteries also developed more spontaneous tone than WKY arteries, which was reversed by 1 µmol/L nifedipine at the end of the experiment. The averaged values in Figure 3C show that the maximal responses of WKY and SHR arteries to Bay K8644 were 2±1% and 104±11% of the maximal contraction to 80 mmol/L KCl, respectively (n=5 each). Figure 3D indicates that SHR mesenteric arteries spontaneously developed 1.6-fold more nifedipine-sensitive tone than WKY arteries (n=5, 7).
|
Similar Profile of
1C Upregulation in Skeletal Muscle Arteries of SHR
A second series of studies further compared the change in amplified cDNA, protein, and functional expression of
1C subunits between WKY and SHR femoral-saphenous arteries. The findings highly resembled those in mesenteric preparations and are condensed in Figure 4. Figure 4A displays cycle-dependent products corresponding to mRNA for smooth muscle
-actin (637 bp) and the
1C subunit (233 bp). The band corresponding to
1C mRNA showed higher photodensity in SHR than WKY VSMC, whereas
-actin expression was comparable at the same amplification cycle. Three RNA isolations pooled from 9 WKY and SHR arteries demonstrated a 3.61-fold increase in the
1C signal measured in the linear range. The immunoblot in Figure 4B demonstrated an upregulation of the
1C subunit protein in SHR skeletal muscle arteries. A 4.1-fold increase in immunoreactivity was observed in 7 different Western blots. Western analysis also was extended to skeletal muscle arteries microdissected from 4-week-old WKY rats and SHR, but as shown by the inset in Figure 4B, there was no evidence for
1C subunit overexpression in arteries of the young SHR. In a population of 68 VSMCs, Figures 4C and 4D indicate that single-cell immunofluorescence associated with the
1C subunit was increased 2.4-fold in SHR cells, whereas the fluorescent signal for
-actin was not significantly different between VSMCs of the two rat strains (data not shown). Figure 4E shows that Bay K8644 dose-dependently increased SHR arteries to 37±81% of the maximal KCl contraction in vascular reactivity studies, compared with a 1±1% response in WKY vessels. Spontaneous tone also was significantly pronounced in SHR but not WKY arteries, as evidenced by a 1.5-fold higher dilator effect of nifedipine in the SHR segments (n=6, 6; data not shown).
|
| Discussion |
|---|
|
|
|---|
1C mRNA and pore-forming protein are upregulated in SHR mesenteric arteries that show anomalous Ca2+-dependent tone. Furthermore, our results indicate that
1C mRNA and protein also are upregulated in SHR VSMCs from skeletal muscle arteries. We interpret these findings to suggest that the upregulation of L-type Ca2+ channels may confer a higher level of Ca2+-dependent tone to SHR vessels, although other factors including a depolarized membrane potential or abnormal Ca2+ channel properties also may amplify Ca2+ influx in the VSMCs of SHR.
Potential Mechanisms for
1C Subunit Upregulation in SHR VSMCs
The
1C gene gives rise to both cardiac (
1C-a) and vascular (
1C-b) splice variants.19 However, because of the low abundance of the
1C-b subunit in VSMC membranes, there is little knowledge about the regulation of this subunit by physiological factors. The present study provides initial evidence that the vascular
1C mRNA and protein are upregulated in VSMC of SHR, although further studies will be needed to determine the molecular basis of this abnormality. In this regard, earlier studies in cardiac myocytes have indicated that transcriptional regulation may increase the abundance of
1C subunits in response to glucocorticoids and norepinephrine.20,21 Additionally, posttranslational alterations of the
1C subunit by regulatory ß and
2
subunits also may alter L-type Ca2+ channel expression by regulating its formation or its targeting and stability in the plasma membrane.22,23 At the moment, it is unclear to what extent
2
and ß subunits are expressed and are functionally important in VSMCs and which factors affect their interaction with the
1C subunit. However, the finding in this study that arterial
1C subunit expression is normal in 4-week SHR but elevated in adult SHR raises the possibility that intraluminal pressure may positively regulate the expression level of arterial L-type Ca2+ channels in vivo. The reports from two other laboratories12,14 that L-type Ca2+ current is increased in SHR compared with WKY mesenteric VSMCs at 6 weeks of age raise the possibility that there may be a critical period between 4 and 6 weeks, during which blood pressure is sufficiently elevated to upregulate
1C subunits in SHR vessels. Alternatively, the overexpression of L-type Ca2+ channels may be a later event in the pathogenesis of hypertension in the SHR that does not rely on an elevated pressure as a primary mechanism for upregulation.
Limitations
Several limitations of the present study should be acknowledged. First, larger arteries rather than arterioles were used to obtain enough vascular tissue to analyze
1C mRNA and protein expression. The possibility exists that
1C mRNA and protein expression may be regulated differently in SHR resistance vessels than in larger arteries, although the abnormally high Ca2+-dependent tone observed in mesenteric and femoral arterioles of SHR is consistent with upregulation of the
1C transcript.46 Second, the small size of rat arteries made it unfeasible to remove the endothelium from arteries before protein and total RNA were isolated. Thus, some contaminating element of the
1C signal emanating from endothelial cells cannot be ruled out in the Western and RT-PCR studies, although two factors argue against its importance. First, there is little evidence that L-type Ca2+ channels are expressed in endothelial cells, which instead are thought to rely on receptor-operated Ca2+ entry for cell function.24 Second, we observed an increased fluorescent signal corresponding to the
1C subunit in isolated VSMCs of SHR, although this evidence for
1C overexpression should be viewed as only complementary to the Western blot findings, indicating an upregulation of the L-type Ca2+ channel. Because VSMCs are the major component of larger arteries, most of the
1C signal probably originated from this cell type. Finally, our study did not directly compare L-type Ca2+ current densities between WKY and SHR VSMCs with patch-clamp methods. Instead, because two established laboratories have already provided detailed evidence that whole-cell and single-channel L-type Ca2+ currents are increased in SHR VSMCs,1215 we chose to focus on the compelling question of the mechanism of this alteration and relied on vascular reactivity studies to evaluate the level of functional Ca2+ channels. Notably, the 3- to 4-fold increase in
1C subunit expression in SHR compared with WKY arteries detected in the present study would appear to fully account for the <2-fold increase in peak L-type Ca2+ current detected in patch-clamp studies of mesenteric VSMCs from the SHR, as reported by Cox and Lozinskaya.13
Physiological and Therapeutic Implications
The entry of Ca2+ into VSMCs through L-type Ca2+ channels plays an obligatory role in the development of myogenic tone and mediates contractile responses to vasoactive stimuli and drugs.25 Thus, the upregulation of the
1C subunit in SHR VSMCs would be expected to enhance myogenic tone in the mesenteric and skeletal muscle circulations that are involved in blood pressure regulation. Additionally, the recent finding that mesenteric arteries from hypertensive patients show an abnormally high component of dihydropyridine-sensitive tone raises the possibility that the
1C subunit may be upregulated in human forms of hypertensive disease.26 Notably, antihypertensive therapies that use organic Ca2+ channel blockers (CCBs) may already benefit from the upregulation of the
1C subunit in hypertension, which may provide an amplified target for drug binding and an increased reliance on Ca2+ entry for contraction. This concept concurs with reports that CCBs lower blood pressure in SHR but do not significantly affect pressure in WKY rats.13 Similarly, nifedipine significantly reduces blood pressure in some humans with essential hypertension but has relatively little effect on blood pressure levels in normotensive individuals.27 Thus, the upregulation of the
1C subunit in some forms of hypertension may predispose an individual to the vasodilator effect of CCBs, and similarly, drug sensitivity differences to CCBs between hypertensive individuals may relate to the further modulation of the
1C gene by other regulatory factors that alter channel expression.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received December 21, 2001; first decision January 25, 2002; accepted June 3, 2002.
| References |
|---|
|
|
|---|
2. Takata Y, Hutchinson JS. Exaggerated hypotensive responses to calcium antagonists in spontaneously hypertensive rats. Clin Exp Hypertens. 1983; 5: 827847.
3. Godfraind T, Kazda S, Wibo M. Effects of a chronic treatment by nisoldipine, a calcium antagonistic dihydropyridine, on arteries of spontaneously hypertensive rats. Circ Res. 1991; 68: 674682.
4. Suzuki H, Zweifach BW, Schmid-Schonbein GW. Glucocorticoid modulates vasodilator response of mesenteric arterioles in spontaneously hypertensive rats. Hypertension. 1996; 27: 114118.
5. Falcone CF, Granger HJ, Meininger GA. Enhanced myogenic activation in skeletal muscle arterioles from spontaneously hypertensive rats. Am J Physiol. 1993; 265: H1847-H1855.[Medline] [Order article via Infotrieve]
6. Arii T, Ohyanagi M, Shibuya J, Iwasaki T. Increased function of the voltage-dependent calcium channels, without increase of Ca2+ release from the sarcoplasmic reticulum in the arterioles of spontaneous hypertensive rats. Am J Hypertens. 1999; 12: 12361242.[CrossRef][Medline] [Order article via Infotrieve]
7. Asano M, Nomura Y, Ito K, Uyama Y, Imaizumi Y, Watanabe M. Increased function of voltage-dependent Ca++ channels and Ca++-activated K+ channels in resting state of femoral arteries from spontaneously hypertensive rats at prehypertensive stage. J Pharmacol Exp Ther. 1995; 275: 775783.
8. Matsuda K, Lozinskaya I, Cox RH. Augmented contributions of voltage-gated Ca2+ channels to contractile responses in spontaneously hypertensive rat mesenteric arteries. Am J Hypertens. 1997; 10: 12311239.[CrossRef][Medline] [Order article via Infotrieve]
9. Rusch NJ, Kotchen TA. Vascular smooth muscle regulation by calcium, magnesium and potassium in hypertension. In: Swales JD, ed. Textbook of Hypertension. London, UK: Blackwell Scientific Publications; 1994: 188199.
10. Field F, Soltis EE. Vascular reactivity in the spontaneously hypertensive rat: effect of high pressure stress and extracellular calcium. Hypertension. 1985; 7: 228235.
11. MacKay MJ, Cheung DW. Increased reactivity in the mesenteric artery of spontaneously hypertensive rats to phorbol ester. Biochem Biophys Res Commun. 1987; 145: 11051111.[CrossRef][Medline] [Order article via Infotrieve]
12. Ohya Y, Abe I, Fujii K, Takata Y, Fujishima M. Voltage-dependent Ca2+ channels in resistance arteries from spontaneously hypertensive rats. Circ Res. 1993; 73: 10901099.
13. Cox RH, Lozinskaya IM. Augmented calcium currents in mesenteric artery branches of the spontaneously hypertensive rat. Hypertension. 1995; 26: 10601064.
14. Lozinskaya IM, Cox RH. Effects of age on Ca2+ currents in small mesenteric artery myocytes from Wistar-Kyoto and spontaneously hypertensive rats. Hypertension. 1997; 29: 13291336.
15. Ohya Y, Tsuchihashi T, Kagiyama S, Abe I, Fujishima M. Single L-type calcium channels in smooth muscle cells from resistance arteries of spontaneously hypertensive rats. Hypertension. 1998; 31: 11251129.
16. Liu X, Rusch NJ, Striessing J, Sarna SK. Down-regulation of L-type calcium channels in inflamed circular smooth muscle cells of the canine colon. Gastroenterology. 2001; 120: 480489.[CrossRef][Medline] [Order article via Infotrieve]
17. Jackson WF, Huebner JM, Rusch NJ. Enzymatic isolation and characterization of single vascular smooth muscle cells from cremasteric arterioles. Microcirculation. 1997; 4: 3550.[Medline] [Order article via Infotrieve]
18. Rusch NJ, Runnells AM. Remission of high blood pressure reverses arterial potassium channel alterations. Hypertension. 1994; 23: 941945.
19. Welling A, Ludwig A, Zimmer S, Klugbauer N, Flockerzi V, Hofmann F. Alternatively spliced IS6 segments of the
1C gene determine the tissue-specific dihydropyridine sensitivity of cardiac and vascular smooth muscle L-type Ca2+ channels. Circ Res. 1997; 81: 526532.
20. Takimoto K, Li D, Nerbonne JM, Levitan ES. Distribution, splicing and glucocorticoid-induced expression of cardiac
1C and
1D voltage-gated Ca2+ channel mRNAs. J Mol Cell Cardiol. 1997; 29: 30353042.[CrossRef][Medline]
[Order article via Infotrieve]
21. Maki T, Gruver EJ, Davidoff AJ, Izzo N, Toupin D, Colucci W, Marks AR, Marsh JD. Regulation of calcium channel expression in neonatal myocytes by catecholamines. J Clin Invest. 1996; 97: 656663.[Medline] [Order article via Infotrieve]
22. Gao T, Chien AJ, Hosey MM. Complexes of the
1C and ß subunits generate the necessary signal for membrane targeting of class C L-type calcium channels. J Biol Chem. 1999; 274: 21372144.
23. Schleithoff L, Mehrke G, Reutlinger B, Lehmann-Horn F. Genomic structure and functional expression of a human
2/
calcium channel subunit gene (CACNA2). Genomics. 1999; 61: 201209.[CrossRef][Medline]
[Order article via Infotrieve]
24. Himmel HM, Whorton AR, Strauss HC. Intracellular calcium, currents, and stimulus-response coupling in endothelial cells. Hypertension. 1993; 21: 112127.
25. Miriel VA, Mauban JR, Blaustein MP, Wier WG. Local and cellular Ca2+ transients in smooth muscle of pressurized rat resistance arteries during myogenic and agonist stimulation. J Physiol. 1999; 518: 815824.
26. Hutri-Kahonen N, Kahonen M, Wu X, Sand J, Nordback I, Taurio J, Porsti I. Control of vascular tone in isolated mesenteric arterial segments from hypertensive patients. Br J Pharmacol. 1999; 127: 17351743.[CrossRef][Medline] [Order article via Infotrieve]
27. Miyamori I, Yasuhara S, Matsubara T, Takasaki H, Takeda R. Effects of a calcium entry blocker on cerebral circulation in essential hypertension. J Clin Hypertens. 1987; 3: 528535.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
X. Cheng, J. Pachuau, E. Blaskova, M. Asuncion-Chin, J. Liu, A. M. Dopico, and J. H. Jaggar Alternative splicing of Cav1.2 channel exons in smooth muscle cells of resistance-size arteries generates currents with unique electrophysiological properties Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H680 - H688. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Rhee, J. R. Stimers, W. Wang, and L. Pang Vascular Smooth Muscle-Specific Knockdown of the Noncardiac Form of the L-Type Calcium Channel by MicroRNA-Based Short Hairpin RNA as a Potential Antihypertensive Therapy J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 775 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Hirenallur-S., S. T. Haworth, J. T. Leming, J. Chang, G. Hernandez, J. B. Gordon, and N. J. Rusch Upregulation of vascular calcium channels in neonatal piglets with hypoxia-induced pulmonary hypertension Am J Physiol Lung Cell Mol Physiol, November 1, 2008; 295(5): L915 - L924. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nieves-Cintron, G. C. Amberg, M. F. Navedo, J. D. Molkentin, and L. F. Santana The control of Ca2+ influx and NFATc3 signaling in arterial smooth muscle during hypertension PNAS, October 7, 2008; 105(40): 15623 - 15628. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Navedo, M. Nieves-Cintron, G. C. Amberg, C. Yuan, V. S. Votaw, W. J. Lederer, G. S. McKnight, and L. F. Santana AKAP150 Is Required for Stuttering Persistent Ca2+ Sparklets and Angiotensin II-Induced Hypertension Circ. Res., February 1, 2008; 102(2): e1 - e11. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Xue, L.-F. Zhang, J. Ma, and M.-J. Xie Differential regulation of L-type Ca2+ channels in cerebral and mesenteric arteries after simulated microgravity in rats and its intervention by standing Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H691 - H701. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sonkusare, M. Fraer, J. D. Marsh, and N. J. Rusch Disrupting Calcium Channel Expression To Lower Blood Pressure: New Targeting of a Well-Known Channel Mol. Interv., December 1, 2006; 6(6): 304 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Godfraind Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis Phil Trans R Soc B, December 29, 2005; 360(1464): 2259 - 2272. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishiguro, T. L. Wellman, A. Honda, S. R. Russell, B. I. Tranmer, and G. C. Wellman Emergence of a R-Type Ca2+ Channel (CaV 2.3) Contributes to Cerebral Artery Constriction After Subarachnoid Hemorrhage Circ. Res., March 4, 2005; 96(4): 419 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Kurjiaka, S. B. Bender, D. D. Nye, W. B. Wiehler, and D. G. Welsh Hypertension attenuates cell-to-cell communication in hamster retractor muscle feed arteries Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H861 - H870. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.R. Wamhoff, D.K. Bowles, O.G. McDonald, S. Sinha, A.P. Somlyo, A.V. Somlyo, and G.K. Owens L-type Voltage-Gated Ca2+ Channels Modulate Expression of Smooth Muscle Differentiation Marker Genes via a Rho Kinase/Myocardin/SRF-Dependent Mechanism Circ. Res., August 20, 2004; 95(4): 406 - 414. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pesic, J. A. Madden, M. Pesic, and N. J. Rusch High Blood Pressure Upregulates Arterial L-Type Ca2+ Channels: Is Membrane Depolarization the Signal? Circ. Res., May 28, 2004; 94(10): e97 - e104. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bonnet, J.-P. Savineau, W. Barillot, E. Dubuis, C. Vandier, and P. Bonnet Role of Ca2+-sensitive K+ channels in the remission phase of pulmonary hypertension in chronic obstructive pulmonary diseases Cardiovasc Res, November 1, 2003; 60(2): 326 - 336. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Albarwani, L. T Nemetz, J. A Madden, A. A Tobin, S. K England, P. F Pratt, and N. J Rusch Voltage-gated K+ channels in rat small cerebral arteries: molecular identity of the functional channels J. Physiol., September 15, 2003; 551(3): 751 - 763. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Gerzanich, S. Ivanova, H. Zhou, and J. M. Simard Mislocalization of eNOS and Upregulation of Cerebral Vascular Ca2+ Channel Activity in Angiotensin-Hypertension Hypertension, May 1, 2003; 41(5): 1124 - 1130. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |